Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCohort Regulatory News (CHRT)

Share Price Information for Cohort (CHRT)

Share Price is delayed by 15 minutes
Get Live Data
1,242.00    -14.00 (-1.11%)
Bid:
1,238.00
Ask:
1,242.00
Spread: 4.00 (0.323%)
Market Cap: £569.16m
CHRT Live PriceLast checked at - London Stock Exchange

Intraday Cohort Share Chart

Director/PDMR Shareholding

14 Aug 2014 09:30

RNS Number : 1263P
Cohort PLC
14 August 2014
 



14 August 2014

COHORT PLC (the "Company")

Director Shareholdings, Share Awards and Options

Cohort plc (the "Company") wishes to notify the following changes in the interests of directors of the Company in ordinary shares of 10 pence in relation to share awards and share options.

Director shareholdings

Yesterday, the Company was notified that the sale of shares to satisfy share option exercise costs took place on 12 August 2014 as follows:

Description

Ordinary Shares

Market Value(pence)

Sale by AS Thomis' wife

25,477

197.25 p

Sale by SR Walther

7,644

197.25 p

Sale by SR Walther's wife

7,643

197.25 p

Following all transactions to date, including those detailed below, and subject to the completion of ISA transfers announced on 5 August 2014, Mr Thomis' and Mr Walther's interests and that of their connected persons are as follows:

Director

Ordinary shares

% of the total issued share capital

AS Thomis

86,225

0.21

SR Walther

78,892

0.19

Grant of Share Awards

On 11 August 2014 share awards pursuant to the 2013 Restricted Share Scheme established on 30 July 2013 ("Restricted Share Scheme") were granted to directors of the Company for nil consideration as follows:

Director

Number of sharesunder this award

Total number of unvested shares under the Restricted Share Scheme following grant

AS Thomis

19,342

20,556

SR Walther

15,595

17,196

Full beneficial ownership of Restricted Shares (including voting and dividend rights) will transfer to the recipients in stages over a three-year period from the date of grant. Recipients may only sell Restricted Shares with the approval of the Chairman of the Remuneration & Appointments Committee while they remain in employment with the Company. Further details regarding the Restricted Shares can be found in the Company's Annual Report and Accounts 2014.

Grant of Share Options

On 11 August 2014 share options pursuant to the Cohort plc 2006 Share Option Scheme ("Unapproved") and the Approved Share Option Subplan ("Approved") were granted to directors of the Company as follows:

Director

Number of shares under this option

Exercise Price(pence)

Total number of shares under option following grant

AS Thomis - Unapproved

4,153

197.5

246,944

Approved

15,189

197.5

15,189

SR Walther - Unapproved

406

197.5

172,580

Approved

15,189

197.5

15,189

The options can be exercised between 12 August 2017 and 11 August 2024.

On 11 August 2014 share options pursuant to the Cohort plc Savings Related Share Option Scheme ("SAYE Scheme") were granted to directors of the Company as follows:

Director

Number of shares underthis option

Exercise Price (pence)

Total number of shares under the SAYE Scheme following grant

AS Thomis

2,602

207.5

4,932

SR Walther

867

207.5

6,692

The options are made pursuant to three year savings contracts.

The total share options held under each scheme following grant as set out above includes the recent exercise of share options announced on 5 August 2014.

Ends

For further information, please contact

Cohort plc

Andrew Thomis, Chief ExecutiveSimon Walther, Finance Director

+44 (0)118 909 0390

Investec

Keith Anderson, Daniel Adams

+44 (0)20 7597 5970

MHP Communications

Reg Hoare, Vicky Watkins

+44 (0)20 3128 8100

Cohort plc

Cohort is an independent technology group working primarily for defence (air, land and sea), wider government and industry clients, through four market-facing subsidiary companies:

MASS - a specialist systems house with considerable experience in the defence market and a focus on electronic warfare operational support and secure information systems. Based in Cambridgeshire, MASS was acquired by Cohort in August 2006;

MCL - an expert in electronic and surveillance technology design and manufacturing, product and in the field support and training for a range of specialist UK end users, including the MOD and other governmental agencies. Based in Surrey, MCL has been part of the Group since July 2014;

SCS - a defence technical advisory business, combining technical expertise with practical experience and domain knowledge. Owned by Cohort since flotation in March 2006;

SEA - an advanced surveillance systems and software house with hardware development capability operating in the defence and transport market sectors. Acquired by Cohort in October 2007.

Cohort was admitted to London's Alternative Investment Market in March 2006. It has its headquarters in Berkshire and employs in total around 500 core staff there and at its other operating company sites in Bristol, Cambridgeshire, Lincolnshire, Somerset and Surrey.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSGIGDIGXBBGSS
Date   Source Headline
1st Jun 202611:41 amRNSTotal Voting Rights
27th May 20267:00 amRNSFull Year Trading Update
26th May 20267:00 amRNSNotice of Full Year Trading Update
12th May 202610:46 amRNSHolding(s) in Company
1st May 20269:37 amRNSTotal Voting Rights
10th Apr 20263:58 pmRNSDirector/PDMR Shareholding
10th Apr 202612:35 pmRNSHolding(s) in Company
2nd Apr 20267:00 amRNSBlock Listing Six Monthly Return
1st Apr 202610:10 amRNSTotal Voting Rights
26th Mar 20267:00 amRNSContract Announcement
23rd Mar 20267:00 amRNSContract Announcement
2nd Mar 202611:57 amRNSTotal Voting Rights
25th Feb 20269:51 amRNSBlock Listing Six Monthly Return
20th Feb 20267:00 amRNSDirector/PDMR Shareholding
17th Feb 20263:41 pmRNSHolding(s) in Company
16th Feb 20267:00 amRNSDirector/PDMR Shareholding
4th Feb 20269:35 amRNSHolding(s) in Company
2nd Feb 20264:54 pmRNSTotal Voting Rights
30th Jan 20267:00 amRNSContract Wins
20th Jan 202612:40 pmRNSHolding(s) in Company
15th Jan 20267:00 amRNSInterim Report 2025
5th Jan 20269:00 amRNS-RInvestor Presentation via Equity Development
2nd Jan 202612:40 pmRNSTotal Voting Rights
22nd Dec 20259:00 amRNS-RInvestor Presentation via Engage Investor
22nd Dec 20259:00 amRNS-RInvestor Presentation via Engage Investor
15th Dec 202511:56 amRNSDirector/PDMR Shareholding
11th Dec 20257:00 amRNSDirector/PDMR Shareholding
10th Dec 20257:01 amRNSHalf Year Results
1st Dec 202512:20 pmRNSTotal Voting Rights
28th Nov 20257:00 amRNSNotice of Half Year Results
4th Nov 202511:59 amRNSTotal Voting Rights
27th Oct 20254:37 pmRNSDirector/PDMR Shareholding
16th Oct 202510:11 amRNSDirector/PDMR Shareholding
7th Oct 20253:15 pmRNSDirector/PDMR Shareholding
7th Oct 20257:00 amRNSMASS secures £15.7m countermeasures contract
2nd Oct 202511:03 amRNSBlock Listing Six Monthly Return
1st Oct 20259:53 amRNSTotal Voting Rights
25th Sep 20254:59 pmRNSResult of AGM
25th Sep 20257:00 amRNSAGM Statement
19th Sep 20255:12 pmRNSDirector/PDMR Shareholding
12th Sep 20257:00 amRNS-RInvestor Presentation
10th Sep 20253:21 pmRNSDirector/PDMR Shareholding
3rd Sep 202510:57 amRNSDirector/PDMR Shareholding
1st Sep 202511:05 amRNSTotal Voting Rights
26th Aug 20253:22 pmRNSBlock Listing Six Monthly Return
20th Aug 20253:56 pmRNSAnnual Report and Notice of Annual General Meeting
15th Aug 20253:35 pmRNSDirector/PDMR Shareholding
11th Aug 20255:10 pmRNSDirector/PDMR Shareholding
1st Aug 20254:16 pmRNSTotal Voting Rights
17th Jul 20259:49 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.